-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Don’t Mess With Canopy Growth Stock Until CGC Reports Earnings
Given the increased risks for bulls and bears, we can expect CGC stock to present a stronger trade after the earnings reaction, not before.
Molson Coors May Be the Only Thing Propping Up HEXO Stock
As I stated in July, the Truss partnership with Hexo is ready to go when the legalization of cannabis-infused drinks happens in October, and distribution rolls out in December after the required 60-day waiting period.
4 Reasons to Buy Hexo Stock Despite the Rough Ride
Hexo stocks hasn't had the best luck lately, but interested investors might be wise to view this as a buying opportunity.
6 Catalysts That Say National Marijuana Legalization Is Nigh
Matt McCall walks us through the ENORMOUS implications for marijuana investors as the road to marijuana legalization gets shorter and shorter.
Canopy Growth Stock Is a Buy Near $32
While the current valuation for CGC is insane, Canopy Growth stock will grow into it with time, making it a promising long-term play.
Why It’s Not Time to Buy Hexo Stock Yet
It's unclear if Hexo stock can meet its aggressive growth plans for 2020. Meanwhile, its marketing practices are coming under scrutiny.
Hexo Stock Is Almost Worth Buying Now
HEXO stock has a lot of headwinds to deal with, so you should wait for it to come in some more before nibbling at it.
These Are the 4 Reasons HEXO Stock Is Tanking Right Now
HEXO stock has taken a big hit in the past three months along with the rest of the cannabis stock group. Factors such as aggressive guidance, cannabis pricing pressures and new Canadian regulations have weighed on enthusiasm for Hexo.
Hexo Stock Has Potential, But Skip It for Now
The Canadian market has runway with edibles and beverages. But the real growth driver is the United States. Once Hexo and its competitors can expand south into America, investors will have a clearer picture of the industry's growth potential. Until then, the stock is not a buy. But long-term, HEXO stock may be a smart way to play the cannabis growth story.
3 Potential Catalysts That Could Send Tilray Shares Soaring
Despite falling from the highs, TLRY has potential. Here are three potential positive catalysts that could unlock Tilray's potential.
Cannabis Bulls Should Consider HEXO Stock … Eventually
HEXO stock is a classic falling knife right now, but could be a value play once it finds a bottom.
Hot Investing Trends Updates: IoT, EV, Streaming Video and Marijuana Legalization
From IoT to marijuana legalization, Matt McCall rounds up the latest news to help you make money in the world’s biggest investment themes.
Aurora Cannabis Stock Is the Bitcoin of Equity Markets
Aurora Cannabis has a large addressable market globally. However, inventory build-up is a near-term concern, and growth in the medicinal segment needs to be watched.
Marijuana Stocks: How to Start Investing in Pot’s Explosive Growth
Legal marijuana is slated to skyrocket from less than $10 billion today, into a $100 BILLION juggernaut -- making marijuana stocks the biggest investment opportunity over the next few years.
Aurora Cannabis Stock Has a Cash Burn Problem
ACB stock has come down to earth now that analysts are taking a closer look at the company's balance sheet. If Nelson Peltz doesn't find Aurora a partner soon, Aurora stock may find itself in a capital crunch.
$30 Is Still a Possibility for Canopy Growth Stock
The price of CGC stock may soon drop to $30. There isn't much support around the levels where it is currenly trading.
